Discover the advantage of choosing OmniAb for antibody discovery
OmniAb partners enjoy full access to the most comprehensive and cutting-edge suite of clinically proven antibody discovery technologies available. As your antibody discovery company, we work closely with you to find the leads that will be most beneficial for the development of your product. We offer validated and proprietary transgenic animals capable of generating high-quality, fully human antibodies. Because each one provides a distinct immune response profile, we are the biotech company that can match you with the ideal therapeutic candidate.
a unique innovation in
transgenic animal platforms
Because chickens are evolutionarily more distant than rodents are to humans, they produce stronger and more diverse antibody responses to many target antigens, especially those that are conserved among mammals. This makes chickens ideal immunization hosts for therapeutic antibody discovery.
releases about OmniAb technology.
What's New at OmniAb
Read the latest news and press releases about OmniAb technology.
Publications & Presentations
Search and browse recent presentations and peer-reviewed publications about OmniAb technology
Become an OmniAb partner
See how more than 55 biopharmaceutical companies and research institutions worldwide are using OmniAb technology and capabilities to advance clinical drug development. No other transgenic company serving the marketplace today offers the level of expertise and collaborative approach that we do. OmniAb provides the industry with several transgenic animal species. When you choose to work with us as your therapeutics company, we bring an exceptional amount of depth on our scientific team, meaning you can always expect the best from us.
Get in Touch
Learn about our antibody discovery services
and find out which could work best for you.